IN THE NEWS
-
COMBINED GENERAL MEETING
IntegraGen's Combined Ordinary and Extraordinary General Meeting will be held on September 17 at 2pm at the company's head office: Génopole Campus 1, Genavenir 8, Porte 840, 5 rue... Read More
-
WHAT'S NEW FOR MERCURY?
Latest update: MERCURY™ v3.0 We are delighted to present the new version of MERCURY (v3.0). This release includes a number of updates... Read More
-
AGREEMENT ON A FRIENDLY TAKEOVER BID BY ONCODNA FOR INTEGRAGEN
Agreement on a friendly takeover bid by ONCODNA for INTEGRAGEN at €2.20 per share, for the entire share capital. This operation would combine... Read More
LATEST NEWS
-
INTEGRAGEN - S1 2020 SALES OF €4.7M UP +13 % AND CASH POSITION OF €5.8M
IntegraGen today announces its unaudited sales figures for the first half of 2020. The sales... Read More
-
INTEGRAGEN ACHIEVES CE MARKING FOR MERCURY™, A CLOUD-BASED SOFTWARE APPLICATION FOR INTERPRETING MOLECULAR DATA FROM CANCER PATIENTS' TUMORS
IntegraGen announces the CE marking of its cloud-hosted online software application,... Read More
-
INTEGRAGEN UPDATE - ALWAYS OPEN FOR YOUR PROJECTS
IntegraGen is following government recommendations and precautionary measures related to the... Read More
-
INTEGRAGEN - ANNUAL RESULTS 2019
Sales growth (+201TP3Q), EBITDA positive in the second half and close to... Read More
